Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluviral New vs Aged Bulk Safety and Immunogenicity
NCT00586469Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2007
- Primary completion
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated) in influenza, sponsored by GSK. Started Dec 2007; status: completed.
02
Drugs
influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00586469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586469.